25
Views
0
CrossRef citations to date
0
Altmetric
Practice Pearl

Review of ONTARGET: Treating Patients at High Risk for Vascular Events with Telmisartan, Ramipril, or Both

, MD
Pages 202-204 | Published online: 13 Mar 2015
 

Practice Pearl

ONTARGET established that an ARB, telmisartan, was equally effective as an ACE inhibitor, ramipril, for reducing cardiovascular events in a broad range of high-risk patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.